Showing results (1441-1450 of 2,907) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|August 26, 2026
Calcium dysregulation in breast cancer progression: mechanisms of calcicoptosis and therapeutic implicationsYu-Ting He, Jun-Hui Yin, Zhuo-Ling Li, et al.Cancer Gene Therapy|August 27, 2026
CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cellsChunli Zhang, Qiuxia Wei, Nigmat Rahim, et al.Cancer Gene Therapy|August 20, 2026
Targeting VPS35 increases chemotherapy sensitivity in gastric cancer cells via regulation of the NF-κB signaling pathwayZhigang Zhang, Wanrui Gao, Ke Liu, et al.Cancer Gene Therapy|August 13, 2026
Targeting HDAC and proteostasis to eradicate quiescent cancer cellsQi Jiang, Michelle Ertel, Austin Arrigo, et al.Cancer Gene Therapy|September 17, 2026
TWF1 inhibition overcomes cisplatin resistance in NSCLC by inducing ferroptosis via p53-dependent SLC7A11 repression and autophagy-mediated glutathione metabolism reprogrammingMengwei Zhang, Yu Wang, Siyi Li, et al.Cancer Gene Therapy|July 23, 2003
Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductaseJean-Philippe Belzile, Antonis Karatzas, Hoi-Ying Shiu, et al.Cancer Gene Therapy|April 30, 2003
Transplantation of prodrug-converting neural progenitor cells for brain tumor therapyVincenza Barresi, Natale Belluardo, Simonetta Sipione, et al.Cancer Gene Therapy|April 30, 2003
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsChangxian Shen, Andreas Buck, Bülent Polat, et al.Cancer Gene Therapy|June 14, 2022
Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS regionShuai He, Jingjing Shi, HongHao Zhou, et al.Cancer Gene Therapy|January 15, 2011
An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune miceE S Gabitzsch, Y Xu, S Balcaitis, et al.Pageof 291